Cardiomatics, the cloud AI tool that allows any trained medical staff to carry out electrocardiogram (ECG) analysis, has raised around €2.7 million in seed funding led by KAYA, the Central and Eastern European VC which has backed companies including Rohlik, Booksy, and DocPlanner. Cardiomatics will use the funding to invest in product development, business activities in existing markets, and prepare the product to launch into new markets.
Founded in 2017 by two digital signal processing engineers, Rafał Samborski and Mariusz Masior, Cardiomatics is transforming how healthcare professionals carry out ECG analysis using AI. ECGs are a simple test that measures a heart’s electrical activity to provide information about heart rate and rhythm, as well as look for causes of chest pain and identify irregular heartbeats. However, it is one of the most difficult areas of diagnostics to teach because of its complex and time-consuming subject matter and often needs a specialist to read and understand the results.
Already, over 3 million hours of ECG signals have been analysed commercially by the AI tool. It is used on a daily basis by more than 700 customers in 10+ countries, including Switzerland, Denmark, Germany and Poland. The tool received European medical device certification in 2018, one of the first-ever for an AI tool.